Creative Drama on Gender Role Stress, Attitudes Toward Violence Against Women, and Aggression
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexMale
Age18-65
SponsorAtaturk University
About this trial
This study aims to examine the effect of Creative Drama on gender role stress, attitudes toward violence against women, and aggression among men who experienced the February 6, 2023 earthquake in Türkiye (centered in Kahramanmaraş).
A total of 75 men (25 experimental, 25 placebo, and 25 control) will participate in the study. The experimental group will take part in a creative drama program, the placebo group will watch films focusing on masculinity roles and violence for 10 weeks, and no intervention will be applied to the control group.
Data will be collected using the Gender Role Stress Scale for Men, the Attitudes Toward Violence Against Women Scale, and the Buss-Perry Aggression Questionnaire - Short Form, and will be analyzed by an independent statistician.
The study aims to enhance the psychological well-being of men affected by the earthquake in Türkiye, reduce violence against women, and contribute to gender equality.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
None
Disqualifiers
None
Trial design
Design model
Parallel
Treatments tested in this trial
Creative Drama Program
BehavioralA structured 10-week Creative Drama program designed to reduce gender role stress, negative attitudes toward violence against women, and aggressive behaviors. Each session will include warm-up activities, improvisation, role-playing, and reflection components. Sessions will be conducted once a week for 90 minutes by a certified drama educator.
Film Viewing Sessions
BehavioralParticipants in the placebo group will watch 10 Turkish films over a 10-week period (one per week) that include themes of masculinity, gender roles, and violence. This intervention is designed as an attention-control condition to match the structure of the experimental group without providing therapeutic content.
Treatment groups
75 Participants
are divided into 3 treatment groupsGroup A: Arm 1: Experimental GroupExperimental treatment 1 intervention
Group B: Arm 2 - Placebo GroupPlacebo comparator 1 intervention
Group C: Arm 3 - Control GroupNo intervention 0 interventions
Trial outcomes
Primary outcomes
1
Change in Male Gender Role Stress Levels
To evaluate the effect of the Creative Drama Program on gender role stress among men who experienced the 2023 Türkiye earthquake. The Gender Role Stress Scale for Men will be used to measure changes in perceived gender-related stress. The minimum score that can be obtained from the scale is 27, and the maximum score is 130. Higher scores indicate a higher level of gender role stress in the individual.
Time frame
Baseline (Week 0) and 10 weeks after intervention2
Change in Attitudes Toward Violence Against Women
To assess the impact of the Creative Drama Program on men's attitudes toward violence against women. The Attitudes Toward Violence Against Women Scale will be administered to measure changes in participants' beliefs and attitudes. For the overall scale, the minimum possible score is 30 and the maximum score is 150. Higher scores indicate a negative attitude toward violence against women (i.e., the individual is opposed to violence against women), whereas lower scores indicate a positive attitude toward violence against women (i.e., the individual is not opposed to violence against women).
Time frame
Baseline (Week 0) and 10 weeks after intervention3
Change in Aggression Levels
To determine the effect of the Creative Drama Program on aggression among male earthquake survivors. The Buss-Perry Aggression Questionnaire - Short Form will be used to assess total aggression and subscale scores (physical aggression, verbal aggression, anger, and hostility). For the overall scale, the minimum possible score is 29 and the maximum score is 145. As the score increases, the level of aggression also increases.
Time frame
Baseline (Week 0) and 10 weeks after interventionLocations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov
This trial is not recruiting at the moment. You can still explore other options: